Practical Adults 4 min read

Off-Label Drug Use in China: Management Guideline 2021 Explained

Off-label drug use is sometimes a reasonable clinical need but carries safety and legal risk. China's 2021 management guideline (Peking Union + Lanzhou University) sets the first standardized, governed procedure for it.

Updated 2022-09-23 · Reviewed for clinical accuracy
Off-Label Drug Use in China: Management Guideline 2021 Explained

What is off-label use?

The first national management guideline

Core principles

What it means for patients

In short

“Off-Label Drug Use in China: Management Guideline 2021 Explained” is part of iMedCompanion’s plain-language library for international patients travelling to China for care. It explains what usually happens, what to prepare, and where to find related specialists and hospitals.

Key facts

  • Published in English
  • Reading time shown on every guide
  • Links to related specialists and hospitals
  • Reviewed for clinical accuracy

Frequently asked questions

Is this guide medical advice?

No. It explains what usually happens so you can ask better questions; decisions are made with your own specialist.

Can I get the guide in Chinese?

The guides are published in English; interpretation and translation are arranged as a separate service.

How do I find a specialist for this?

Each guide links to related specialists and hospitals, or you can send an enquiry and a medical advisor will match you.

Keep reading

Related guides

All medical guides →
Live Chat